Mailing Address:
Harvard Medical School
Department of Population Medicine
133 Brookline Avenue, 6th Floor
Boston, MA 02215
Dennis_Ross-Degnan@hms.harvard.edu
Phone: (617) 509-9920
Fax: (617) 859-9853
Websites
INRUD
WHOCCPP
|
Dennis Ross-Degnan, ScD
Dennis Ross-Degnan, Sc.D., is Associate Professor at the Department of Population Medicine at Harvard Medical School and Director of Research at Harvard Pilgrim Health Care. He holds a doctorate in health policy and management from the Harvard School of Public Health. Dr. Ross-Degnan is one of the global leaders in improving use of medicines. His career has focused on improving health systems in the US and developing countries, including research on the factors underlying use of medicines, impacts of pharmaceutical policies on utilization and clinical outcomes, interventions to improve quality of care, and appropriate methods for pharmaceutical research. In 1990, he co-founded the International Network for Rational Use of Drugs (INRUD), a global network of academics, health managers, and policymakers involved in developing and testing interdisciplinary interventions to improve use of medicines. In recognition of these efforts, he was awarded the 2005 HMS Klaus Peter International Teaching Award. Dr. Ross-Degnan has consulted extensively with the World Health Organization on issues related to pharmaceutical access and appropriate use, and co-directs the WHO Collaborating Center on Pharmaceutical Policy based jointly at DPM and the Boston University Center for International Health.
Selected Publications:
Bertoldi AD,de Barros AJ,Wagner A,Ross-Degnan D,Hallal PC,.
Medicine access and utilization in a population covered by primary health care in Brazil
.
Health Policy. 2009 Mar;3:295-302
Zhang F,Wagner AK,Soumerai SB,Ross-Degnan D,.
Methods for estimating confidence intervals in interrupted time series analyses of health interventions
.
J Clin Epidemiol. 2009 Feb;2:143-148
Cameron A,Ewen M,Ross-Degnan D,Ball D,Laing R,.
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
.
Lancet. 2009 Jan 17;9659:240-249
Fortuna RJ,Ross-Degnan D,Finkelstein J,Zhang F,Campion FX,Simon SR,.
Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice
.
J Eval Clin Pract. 2008 Dec;6:969-973
Goldman RE,Sanchez-Hernandez M,Ross-Degnan D,Piette JD,Trinacty CM,Simon SR,.
Developing an automated speech-recognition telephone diabetes intervention
.
Int J Qual Health Care. 2008 Aug;4:264-270
Chalker J,Andualem T,Minzi O,Ntaganira J,Ojoo A,Waako P,Ross-Degnan D,.
Monitoring adherence and defaulting for antiretroviral therapy in 5 East african countries: an urgent need for standards
.
J Int Assoc Physicians AIDS Care (Chic Ill ). 2008 Jul;4:193-199
Morden NE,Zerzan JT,Rue TC,Heagerty PJ,Roughead EE,Soumerai SB,Ross-Degnan D,Sullivan SD,.
Medicaid prior authorization and controlled-release oxycodone
.
Med Care. 2008 Jun;6:573-580
Tjia J,Briesacher BA,Soumerai SB,Pierre-Jacques M,Zhang F,Ross-Degnan D,Gurwitz JH,.
Medicare beneficiaries and free prescription drug samples: a national survey
.
J Gen Intern Med. 2008 Jun;6:709-714
Law MR,Ross-Degnan D,Soumerai SB,.
Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements
.
Psychiatr Serv. 2008 May;5:540-546
Soumerai SB,Zhang F,Ross-Degnan D,Ball DE,LeCates RF,Law MR,Hughes TE,Chapman D,Adams AS,.
Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change
.
Health Aff (Millwood ). 2008 May;3:w185-w195
Adams AS,Trinacty CM,Zhang F,Kleinman K,Grant RW,Meigs JB,Soumerai SB,Ross-Degnan D,.
Medication adherence and racial differences in A1C control
.
Diabetes Care. 2008 May;5:916-921
Wharam JF,Galbraith AA,Kleinman KP,Soumerai SB,Ross-Degnan D,Landon BE,.
Cancer screening before and after switching to a high-deductible health plan
.
Ann Intern Med. 2008 May 6;9:647-655
Madden JM,Graves AJ,Zhang F,Adams AS,Briesacher BA,Ross-Degnan D,Gurwitz JH,Pierre-Jacques M,Safran DG,Adler GS,Soumerai SB,.
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D
.
JAMA. 2008 Apr 23;16:1922-1928
Pierre-Jacques M,Safran DG,Zhang F,Ross-Degnan D,Adams AS,Gurwitz J,Rusinak D,Soumerai SB,.
Reliability of new measures of cost-related medication nonadherence
.
Med Care. 2008 Apr;4:444-448
Law MR,Soumerai SB,Ross-Degnan D,Adams AS,.
A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia
.
J Clin Psychiatry. 2008 Jan;1:47-53
Finkelstein JA,Huang SS,Kleinman K,Rifas-Shiman SL,Stille CJ,Daniel J,Schiff N,Steingard R,Soumerai SB,Ross-Degnan D,Goldmann D,Platt R,.
Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts
.
Pediatrics. 2008 Jan;1:e15-e23
Bertoldi AD,Barros AJ,Wagner A,Ross-Degnan D,Hallal PC,.
A descriptive review of the methodologies used in household surveys on medicine utilization
.
BMC Health Serv Res. 2008;222-
Wagner AK,Valera M,Graves AJ,Lavina S,Ross-Degnan D,.
Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines
.
BMC Health Serv Res. 2008;161-
Lu CY,Ross-Degnan D,Soumerai SB,Pearson SA,.
Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007
.
BMC Health Serv Res. 2008;75-
Vialle-Valentin CE,Ross-Degnan D,Ntaganira J,Wagner AK,.
Medicines coverage and community-based health insurance in low-income countries
.
Health Res Policy Syst. 2008;11-
|
